Preeclampsia up to date—What’s going on?

Preeclampsia is a hypertensive disorder in pregnancy characterized by placental malperfusion and subsequent multi-organ injury. It accounts for approximately 14% of maternal deaths and 10–25% of perinatal deaths globally. In addition, preeclampsia has been attracting attentions for its association w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokuda, Kanako, Ichihara, Atsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235860/
https://www.ncbi.nlm.nih.gov/pubmed/37268721
http://dx.doi.org/10.1038/s41440-023-01323-w
_version_ 1785052787841695744
author Bokuda, Kanako
Ichihara, Atsuhiro
author_facet Bokuda, Kanako
Ichihara, Atsuhiro
author_sort Bokuda, Kanako
collection PubMed
description Preeclampsia is a hypertensive disorder in pregnancy characterized by placental malperfusion and subsequent multi-organ injury. It accounts for approximately 14% of maternal deaths and 10–25% of perinatal deaths globally. In addition, preeclampsia has been attracting attentions for its association with risks for developing chronic diseases in later life for both mother and child. This mini-review discusses on latest knowledge on prediction, prevention, management, and long-term outcomes of preeclampsia and also touches on association between COVID-19 and preeclampsia. [Figure: see text]
format Online
Article
Text
id pubmed-10235860
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-102358602023-06-06 Preeclampsia up to date—What’s going on? Bokuda, Kanako Ichihara, Atsuhiro Hypertens Res Mini Review Preeclampsia is a hypertensive disorder in pregnancy characterized by placental malperfusion and subsequent multi-organ injury. It accounts for approximately 14% of maternal deaths and 10–25% of perinatal deaths globally. In addition, preeclampsia has been attracting attentions for its association with risks for developing chronic diseases in later life for both mother and child. This mini-review discusses on latest knowledge on prediction, prevention, management, and long-term outcomes of preeclampsia and also touches on association between COVID-19 and preeclampsia. [Figure: see text] Springer Nature Singapore 2023-06-02 /pmc/articles/PMC10235860/ /pubmed/37268721 http://dx.doi.org/10.1038/s41440-023-01323-w Text en © The Author(s), under exclusive licence to The Japanese Society of Hypertension 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Mini Review
Bokuda, Kanako
Ichihara, Atsuhiro
Preeclampsia up to date—What’s going on?
title Preeclampsia up to date—What’s going on?
title_full Preeclampsia up to date—What’s going on?
title_fullStr Preeclampsia up to date—What’s going on?
title_full_unstemmed Preeclampsia up to date—What’s going on?
title_short Preeclampsia up to date—What’s going on?
title_sort preeclampsia up to date—what’s going on?
topic Mini Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235860/
https://www.ncbi.nlm.nih.gov/pubmed/37268721
http://dx.doi.org/10.1038/s41440-023-01323-w
work_keys_str_mv AT bokudakanako preeclampsiauptodatewhatsgoingon
AT ichiharaatsuhiro preeclampsiauptodatewhatsgoingon

Ejemplares similares